missing translation for 'onlineSavingsMsg'
Learn More

UNC1079, MedChemExpress

Product Code. 16419997
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16419997

Brand: Medchem Express HY18373

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress UNC1079 is the piperidine analog of UNC1021, as a structurally similar but significantly less potent inhibitor for use as a negative control in cellular studies.

UNC1079 is the piperidine analog of UNC1021, as a structurally similar but significantly less potent inhibitor for use as a negative control in cellular studies.

Specifications

Chemical Name or Material UNC1079
CAS 1418741-86-2
Color White
Purity Grade Notes Research
Molecular Formula C28H42N4O2
Quantity 5 mg
Solubility Information DMSO : 2.22 mg/mL (4.76 mM; ultrasonic and warming and heat to 60°C)
SMILES O=C(N1CCC(N2CCCCC2)CC1)C3=CC=C(C(N4CCC(N5CCCCC5)CC4)=O)C=C3
Molecular Weight (g/mol) 466.66
Formula Weight 466.66
Percent Purity 98.0%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.